ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Oregon » Endocrinology, Diabetes Metabolism

Top Endocrinology, Diabetes Metabolism Prescribers in Oregon

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOHN GALLEN M.D.

Endocrinology, Diabetes Metabolism

5,194

$757K

555
413 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 47%

$146
Average prescription price

Avg: $131

RICHARD EDDY MD

Endocrinology, Diabetes Metabolism

5,023

$565K

383
284 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 47%

$112
Average prescription price

Avg: $131

PATRICK MCCARTHY M.D.

Endocrinology, Diabetes Metabolism

4,547

$461K

333
250 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 47%

$101
Average prescription price

Avg: $131

RICHARD BERGSTROM MD

Endocrinology, Diabetes Metabolism

4,435

$644K

325
254 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 47%

$145
Average prescription price

Avg: $131

MARY CARROLL M.D.

Endocrinology, Diabetes Metabolism

4,192

$514K

454
364 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 47%

$123
Average prescription price

Avg: $131

JAMES NEIFING MD

Endocrinology, Diabetes Metabolism

4,184

$533K

346
277 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 47%

$127
Average prescription price

Avg: $131

RODNEY MICHAELS MD

Endocrinology, Diabetes Metabolism

3,998

$645K

289
185 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 47%

$161
Average prescription price

Avg: $131

NICHOLAS CLARKE MD

Endocrinology, Diabetes Metabolism

3,983

$464K

318
238 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 47%

$117
Average prescription price

Avg: $131

JAMES BEARD MD

Endocrinology, Diabetes Metabolism

3,711

$505K

295
201 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 47%

$136
Average prescription price

Avg: $131

STEPHEN BOOKIN MD

Endocrinology, Diabetes Metabolism

3,463

$459K

290
245 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 47%

$133
Average prescription price

Avg: $131

RICK GOLDSTEIN M.D.

Endocrinology, Diabetes Metabolism

3,456

$455K

333
261 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 47%

$132
Average prescription price

Avg: $131

DIANE KARL MD

Endocrinology, Diabetes Metabolism

2,547

$266K

165
130 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 47%

$104
Average prescription price

Avg: $131

SCOTT GRADY MD

Endocrinology, Diabetes Metabolism

2,488

$373K

212
154 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 47%

$150
Average prescription price

Avg: $131

THOMAS CHAMBERLIN MD

Endocrinology, Diabetes Metabolism

2,449

$259K

229
175 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

54%
prescriptions for brand name drugs

Avg: 47%

$106
Average prescription price

Avg: $131

PATRICIA BURFORD MD

Endocrinology, Diabetes Metabolism

2,432

$198K

385
322 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 47%

$82
Average prescription price

Avg: $131

JAMES THEEN MD

Endocrinology, Diabetes Metabolism

2,368

$286K

338
286 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

55%
prescriptions for brand name drugs

Avg: 47%

$121
Average prescription price

Avg: $131

JOSEPH MALLOV M.D

Endocrinology, Diabetes Metabolism

2,348

$319K

230
170 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 47%

$136
Average prescription price

Avg: $131

NANCY CUROSH MD

Endocrinology, Diabetes Metabolism

2,340

$332K

178
130 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

61%
prescriptions for brand name drugs

Avg: 47%

$142
Average prescription price

Avg: $131

JANE FARMER M.D.

Endocrinology, Diabetes Metabolism

2,236

$136K

379
293 are 65+

7%
patients receiving schedule two controlled substances

Avg: 0%

26%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 47%

$61
Average prescription price

Avg: $131

MARGARET VAJDOS MD

Endocrinology, Diabetes Metabolism

2,209

$180K

96
73 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

13%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 47%

$81
Average prescription price

Avg: $131

ANDREW AHMANN MD

Endocrinology, Diabetes Metabolism

2,098

$271K

143
99 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 47%

$129
Average prescription price

Avg: $131

RONALD CIRULLO MD

Endocrinology, Diabetes Metabolism

2,085

$358K

288
201 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 47%

$172
Average prescription price

Avg: $131

PRIYA KRISHNAMURTHY M.D.

Endocrinology, Diabetes Metabolism

2,043

$312K

219
156 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

55%
prescriptions for brand name drugs

Avg: 47%

$153
Average prescription price

Avg: $131

GERALD YOUKER MD

Endocrinology, Diabetes Metabolism

2,035

$187K

229
183 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

58%
prescriptions for brand name drugs

Avg: 47%

$92
Average prescription price

Avg: $131

TROY DILLARD MD

Endocrinology, Diabetes Metabolism

1,862

$163K

185
157 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 47%

$88
Average prescription price

Avg: $131

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank